BSX Boston Scientific Corp

  1. Stocks
  2. Healthcare
  3. NYSE: BSX

Price (delayed)

$44.5

Market cap

$66.14B

P/E Ratio

18.46

Dividend/share

N/A

EPS

$2.41

Enterprise value

$75.72B

?
Relative Growth: Rel. Growth: 96
Relative Strength: Rel. Strength: 4
Relative Valuation: Rel. Valuation: 75
Relative Profitability: Rel. Profitability: 91

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, ...

Highlights
The EPS has soared by 75% YoY and by 23% from the previous quarter
Boston Scientific's net income has surged by 75% YoY and by 23% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: https://www.bostonscientific.com/
Peers: EW SYK MMSI MDT

Key stats

What are the main financial stats of BSX

BSX stock price

How has the Boston Scientific stock price performed over time
Intraday
0.38%
1 week
-5.16%
1 month
-22.98%
1 year
-56.53%
YTD
-53.33%
QTD
-29.08%

Financial performance

How have Boston Scientific's revenue and profit performed over time
Revenue
$20.62B
Gross profit
$14.26B
Operating income
$3.79B
Net income
$3.57B
Gross margin
69.2%
Net margin
17.3%
Boston Scientific's net income has surged by 75% YoY and by 23% QoQ
Boston Scientific's net margin has increased by 49% YoY and by 20% QoQ
Boston Scientific's operating income has increased by 33% YoY and by 4.9% from the previous quarter
Boston Scientific's gross profit has increased by 18% YoY and by 2.9% QoQ

Price vs fundamentals

How does BSX's price correlate with its fundamentals

Growth

What is Boston Scientific's growth rate over time

Valuation

What is Boston Scientific stock price valuation
BSX P/E details
P/E
18.46
P/B
2.55
P/S
3.21
EV/EBIT
18.45
EV/EBITDA
13.77
EV/Sales
3.67
The EPS has soared by 75% YoY and by 23% from the previous quarter
The P/E is 74% below the 5-year quarterly average of 69.8 and 61% below the last 4 quarters average of 47.4
The stock's price to book (P/B) is 55% less than its last 4 quarters average of 5.7 and 46% less than its 5-year quarterly average of 4.7
The equity has grown by 16% YoY and by 7% from the previous quarter
BSX's P/S is 54% below its last 4 quarters average of 6.9 and 49% below its 5-year quarterly average of 6.2
The revenue has increased by 17% YoY and by 2.7% from the previous quarter

Efficiency

How efficient is Boston Scientific business performance
The return on assets has surged by 57% year-on-year and by 20% since the previous quarter
The return on equity has surged by 55% year-on-year and by 18% since the previous quarter
BSX's ROIC is up by 30% YoY and by 7% from the previous quarter
The ROS has increased by 24% YoY and by 7% from the previous quarter

Dividends

What is BSX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for BSX.

Financial health

How did Boston Scientific financials performed over time
Boston Scientific's total assets is 143% more than its total liabilities
BSX's quick ratio is up by 44% year-on-year and by 9% since the previous quarter
BSX's current ratio is up by 31% year-on-year and by 17% since the previous quarter
Boston Scientific's debt is 57% lower than its equity
The equity has grown by 16% YoY and by 7% from the previous quarter
Boston Scientific's debt to equity has decreased by 16% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.